COMMUNIQUÉS West-GlobeNewswire

Saniona AB: Saniona Establish Equity Financing of up to SEK 144 million

29/12/2017 - 16:35

PRESS RELEASE December 29, 2017 Saniona AB, a leading biotech company in the field of ion channels, announced today that it has entered into a convertible notes funding agreement with Nice & Green S.A. Under the [...]

Canada House Wellness Group Announces The Retirement of Interim CEO Gerry Goldberg

29/12/2017 - 15:52

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 29, 2017 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“ Canada House ” or the “ Company ”) announces [...]

Galena Biopharma, Inc. Stockholders Approve Business Combination with SELLAS Life Sciences Group, Ltd; Board Sets Reverse Stock Split Ratio

29/12/2017 - 15:25

SAN RAMON, Calif., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ: GALE ) (“Galena”) announced today that its stockholders approved nine proposals at the reconvened Special Meeting of Stockholders held [...]

Alpha Pro Tech, Ltd. Names Lloyd Hoffman as President; Appoints Donna Millar to Board of Directors

29/12/2017 - 14:50

NOGALES, Ariz., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Alpha Pro Tech, Ltd. (NYSE American: APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective [...]

Delcath Announces Exit from Convertible Note

29/12/2017 - 14:35

NEW YORK, Dec. 29, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces on December 28, 2017, it [...]

Progenics Pharmaceuticals Announces FDA Acceptance of New Drug Application for AZEDRA® (iobenguane I 131) in Pheochromocytoma and Paraganglioma

29/12/2017 - 14:30

NEW YORK, Dec. 29, 2017 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX ), an oncology company developing innovative medicines and imaging analytical tools for targeting and treating cancer, announced [...]

Hemispherx Biopharma, Inc. to Present at Biotech Showcase™ 2018

29/12/2017 - 14:30

ORLANDO, Fla., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB), focused on pharmaceutical research, today announced, that it will be presenting at the Biotech Showcase™ 2018. The conference [...]

Abiomed to Present at the 36th Annual J.P. Morgan Healthcare Conference

29/12/2017 - 14:00

DANVERS, Mass., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc . (NASDAQ: ABMD ), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief [...]

Albireo Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

29/12/2017 - 14:00

BOSTON, Dec. 29, 2017 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO ), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant to two employees [...]

Clean Eating for the New Year - Dentist Doug Disraeli Gives Dental Tips for a Healthy Mouth When Starting a New Diet

29/12/2017 - 13:30

SAN DIEGO, Dec. 29, 2017 (GLOBE NEWSWIRE) -- With words like “orthorexia” and “clean eating” recently added to the Merriam Webster dictionary, Hillcrest dentist Dr. Doug Disraeli gives tips for living up to New Year’s [...]

Avadel Pharmaceuticals Issues 2018 Corporate Outlook

29/12/2017 - 13:30

Commercial launch for Noctiva™ on target for second quarter 2018 NDA filing for FT218 expected by year-end 2018 Total revenues expected to range from $110 - 130 million DUBLIN, Ireland, Dec. 29, 2017 (GLOBE NEWSWIRE [...]

ZAGENO - Biotech E-commerce Platform hits 1.4 Million Products

29/12/2017 - 13:00

BOSTON and BERLIN, Dec. 29, 2017 (GLOBE NEWSWIRE) -- ZAGENO Inc. , the fast-growing digital marketplace for research materials, has developed an impressive portfolio, making it the first choice for purchasing and [...]

GW Pharmaceuticals Submits Marketing Authorisation Application in Europe for Epidiolex® (cannabidiol) in the treatment of Lennox-Gastaut syndrome and Dravet syndrome

29/12/2017 - 13:00

LONDON and CARLSBAD, Calif., Dec. 29, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel [...]

Recro Pharma Reports Inducement Grants for New Staff

29/12/2017 - 13:00

MALVERN, Pa., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq: REPH ), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings, today [...]

Atara Biotherapeutics Announces FDA Clearance to Initiate Two Phase 3 Clinical Studies to Evaluate Tabelecleucel in Patients with Rituximab-Refractory Epstein-Barr Virus Associated Post-Transplant Lymphoproliferative Disorder (EBV+PTLD)

29/12/2017 - 12:00

– Pivotal studies to commence imminently – – Primary endpoint results and EU conditional marketing authorization submission expected in the first half of 2019 – – Company to host conference call and webcast today at 8: [...]

Veritas and Cannevert Complete Prestudy Visit of the Puerto Rico Clinical Trial Facility

29/12/2017 - 09:05

VANCOUVER, British Columbia, Dec. 29, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) , (“Veritas” or the “Company”) announces that it has completed a prestudy visit of the Fundación [...]

Scythian Announces No Material Change

29/12/2017 - 01:13

TORONTO, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (TSX-V: SCYB ) (Frankfurt: 9SB ) (OTC Pink:SCCYF) (“ Scythian ” or the “ Company ”) is issuing this press release in response to a request by the [...]

Helius Medical Technologies Announces Closing of Second Tranche of Private Placement

29/12/2017 - 01:02

NEWTOWN, Pa., Dec. 28, 2017 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX: HSM ) (TSX:HSM.WT) (OTCQB:HSDT) (“Helius” or the “Company”), a medical technology company focused on neurological wellness, is [...]

Atara Biotherapeutics to Host Corporate Update Conference Call on Friday, December 29, 2017, at 8:00 a.m. EST

29/12/2017 - 00:30

– Company to announce FDA clearance to initiate two Phase 3 tabelecleucel clinical studies – SOUTH SAN FRANCISCO, Calif., Dec. 28, 2017 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a leading off-the- [...]